ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Sys Technologies, Inc.

Sys Technologies, Inc. (SYS)

0.00
0.00
( 0.00% )
업데이트: -

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

SYS 뉴스

공식 뉴스 전용
ducci1 ducci1 8 초 전
WOW There They Go!!
SPY
EyeInTheSky EyeInTheSky 49 초 전
"good news" is an understatement.
HLLK
ducci1 ducci1 51 초 전
Wagg 594C .54 ?
SPY
koolmc koolmc 54 초 전
sure buddy fyi get your eyes checked
QMMM
Gooddolphin Gooddolphin 59 초 전
What next NSAV?... As another week goes by.
NSAV
Huggy Bear Huggy Bear 1 분 전
That is also ... Correct. Unless Foote lied about trying to RS his pet scam again, which given his history of fabrications entirely plausible as well ...
HMBL
ktcougar ktcougar 1 분 전
It's been a beautiful week! Sold maybe 5% of my Jan. and April calls today. Had to take a little off lol. It's been a December to remember lol!
www.stockscores.com/chart.asp?TickerSymbol=ATOM&TimeRange=30&Interval=120&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=4
ATOM
gp22 gp22 1 분 전
.$SPCB: Israel Security crowd finding..May rip big in AHs. Thats the history of $SPCB
SPCB
CommodityCoverage CommodityCoverage 2 분 전
Joining Steve Darling from Proactive, First Phosphate's (PHOS.c FRSPF) CEO, John Passalacqua, detailed two major milestones, the first being the signing of two long-term offtake agreements with creditworthy partners marks a pivotal step in securing the future of the company's operations in Saguenay-
FRSPF
MoneyMaker111 MoneyMaker111 2 분 전
"FFIE is worth $100/share (January Effect)" -Sources

$FFIE
#FFIE
FFIE
rbl100 rbl100 2 분 전
FDA APPROVES FBIO cancer drug !!!!

FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programme
FBIO
LoveItInBishop LoveItInBishop 2 분 전
SFHG 1.39
Carjockey2 Carjockey2 2 분 전
Really chapped arse!!

Imo

$HMB
HMB
marcis marcis 3 분 전
The big question is

How much under valued share price does these clingons need to have

Dudes your are dealing with a company of last years rev’s $360!million

Anyone poking to get cheaper is sick IMO
RDAR
cybldron cybldron 3 분 전
yup keep smoking mr no brain cells left
PHIL
Mark Mark 3 분 전
$SYRA .44, has a gap on the chart to .80
SYRA
AugustaFriends AugustaFriends 3 분 전
$WIMI might do next week; what $QSI has done this week run to $4 area -- just a hunch... take it or leave... lots of great plays all over the place.
QSI WIMI
TenKay TenKay 3 분 전
We still don’t know if FINRA will process one. They didn’t the last time they tried.
HMBL
ducci1 ducci1 3 분 전
Closed 593P .52! Take it! Vix Reverse !!
SPY
copytele copytele 3 분 전
FOLLOWED YOU !
LITM
ulmadi ulmadi 3 분 전
Absolutely wrong!
The lenders look very closely at what the investment will bring them. And they also look very closely at which products
the company wants to finance with it, what the market is like and how profitable the company can be.
And I see a lot of potential in PHIL.
PHIL
F14SVF24 F14SVF24 3 분 전
Your posts are getting longer and longer. Save your breath. Lies.
HMBL
Penny Stocks 2.0 Penny Stocks 2.0 4 분 전
Not concerned one bit, silver is coming. Strong stock, load up!!
HLLK
Tiger Money Tiger Money 4 분 전
Also his tweets with saylor from micro were interesting as well.  Money is backing kurl for sure as buying has been relentless 
KULR

최근 히스토리

Delayed Upgrade Clock